Serum Albumin Is a Strong Predictor of Survival in Patients With Advanced-Stage Non-Small Cell Lung Cancer Treated With Erlotinib

Neoplasma - Slovakia
doi 10.4149/318_151001n512
Full Text
Abstract

Available in full text

Categories
Cancer Research
Date
Authors
Publisher

AEPress, s.r.o.

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy